| Date Filed | Type | Description |
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/16/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/15/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/15/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 09/14/2018 |
4
| GREAT POINT PARTNERS LLC (Former 10% Owner) has filed a Form 4 on Foamix Pharmaceuticals Ltd. |
| 08/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/21/2017 |
4
| GREAT POINT PARTNERS LLC (10% Owner) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 350,000 shares
@ $17.0505, valued at
$6M
Sold 20,000 shares
@ $17.3467, valued at
$346.9k
Sold 10,000 shares
@ $17.4365, valued at
$174.4k
|
|
| 05/15/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 04/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 11/14/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 08/15/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 08/08/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/16/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 02/16/2016 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 07/16/2015 |
4
| Great Point Partners I GP, LLC (10% Owner) has filed a Form 4 on CONNECTURE INC|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 06/12/2015 |
4
| Great Point Partners I GP, LLC (10% Owner) has filed a Form 4 on CONNECTURE INC|
Txns:
| Disposed of 1,375,733 shares
@ $0
Acquired 39,703 shares
@ $0
Acquired 36,493 shares
@ $0
Acquired 47,235 shares
@ $0
Acquired 28,696 shares
@ $0 |
|
| 12/17/2014 |
4
| Great Point Partners I GP, LLC (10% Owner) has filed a Form 4 on CONNECTURE INC|
Txns:
| Converted 5,898,851 shares
@ $0
Sold 395,886 shares
@ $8, valued at
$3.2M
Converted 17,696,553 preferred shares
@ $0 |
|
| 08/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|